Oculis Holding AG — Company profile
Healthcare · Biotechnology · Switzerland
Last price 8.26 USD (Oct 30, 2026, 4:00 PM EST) · Market cap 509.91M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Oculis Holding AG, a clinical-stage biopharmaceutical company, develops drug candidates to treat ophthalmic, neuro-ophthalmic, and neurological diseases in Switzerland and internationally. The company’s lead product candidate is OCS-01, a topical dexamethasone optireach formulation, which is in Phase 3 clinical trials for the treatment of diabetic macular edema; OCS-02, a topical biologic candidate that is in Phase 2b clinical trials for the treatment for dry eye disease; and OCS-05, a disease modifying neuroprotective agent for neurological damage with indications for glaucoma, dry age-related macular degeneration and diabetic retinopathy, and acute optic neuritis. Oculis Holding AG was formerly known as Oculis SA and changed its name to Oculis Holding AG in March 2023. The company was founded in 2017 and is based in Zug, Switzerland.
Details
| Name | Oculis Holding AG |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 60 |
| Founded | 2003 |
| Ceo | Riad Sherif |
| Country | Switzerland |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | CHF |
| Isin | CH1242303498 |
| Cik | 0001953530 |
| Sic | 2834 |
Key executives
| Name | Title |
|---|---|
| Dr. Riad Sherif M.B.A., M.D. | Chief Executive Officer and Director |
| Sylvia Cheung | Chief Financial Officer |
| Gudrun Bachmann Ph.D. | Chief Technology Officer |
| Dr. Ramin Tadayoni M.D., Ph.D. | Chief Scientific Officer |
| Katie Kazem | Chief Legal Officer |
| Virginia R. Dean | Chief Human Resources Officer |
| Páll Ragnar Jóhannesson | Chief Business Officer |
| Rebecca Weil Ph.D. | Chief Commercial Officer |
| Dr. Snehal Shah Pharm.D. | President of Research and Development |
| Dr. Sharon Klier M.D., M.P.H. | Chief Development Officer |
Contact
| Address | Bahnhofstrasse 20, Zug, 6300, Switzerland |
| Phone | 41 41 711 3960 |
| Website | https://oculis.com |